SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies
KW Ng, N Faulkner, K Finsterbusch… - Science …, 2022 - pubmed.ncbi.nlm.nih.gov
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies.
KW Ng, N Faulkner, K Finsterbusch, M Wu, R Harvey… - 2022 - crick.figshare.com
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
KW Ng, N Faulkner, K Finsterbusch, M Wu… - Science Translational …, 2022 - cir.nii.ac.jp
抄録< jats: p> Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) have emerged during the current coronavirus disease 2019 (COVID-19) pandemic …
CoV-2) have emerged during the current coronavirus disease 2019 (COVID-19) pandemic …
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
KW Ng, N Faulkner, K Finsterbusch… - Science …, 2022 - discovery.ucl.ac.uk
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
[PDF][PDF] SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
KW Ng, N Faulkner, K Finsterbusch, M Wu, R Harvey… - 2022 - scholar.archive.org
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
[PDF][PDF] SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
KW Ng, N Faulkner, K Finsterbusch, M Wu, R Harvey… - 2022 - researchgate.net
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies.
KW Ng, N Faulkner, K Finsterbusch… - Science …, 2022 - search.ebscohost.com
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
[引用][C] SARS-CoV-2 S2? targeted vaccination elicits broadly neutralizing antibodies
荒瀬尚 - Science Translational Medicine, 2022 - cir.nii.ac.jp
SARS-CoV-2 S2?targeted vaccination elicits broadly neutralizing antibodies | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …